KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.

Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
In response to the public health emergency, international health organizations, including the World Health Organization, are providing logistical support, laboratory testing, and vaccine distribution assistance. Authorities are using the Ervebo vaccine under a compassionate-use protocol while observational data on its effectiveness against the circulating viral strain is being collected by medical researchers. DR Congo initiates Ebola vaccination efforts as health workers ramp up ring-vaccination strategies around identified infection clusters to contain transmission chains.
Health Ministry Focuses on Ervebo Doses for Medical Staff in Kisangani
Operational challenges such as complex regional infrastructure, ongoing security issues, and high population mobility across border districts pose obstacles to logistics. Cold-chain systems have been established in Kisangani to preserve the ultra-low temperatures necessary for vaccine storage before distribution to outlying health zones. The Ebola vaccination campaign is underway in DR Congo, with civil defense and community health workers conducting outreach programs aimed at improving disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention are partnering with local response units to monitor adverse events and assess immune responses among vaccinated populations. Officials highlighted that early clinical detection, combined with isolation strategies and supportive care, remains vital for increasing survival rates. Additional vaccine shipments are planned as regional distribution expands to secondary health districts.
Authorities Enforce Rigorous Infection Control Procedures at Treatment Facilities
National teams continue expanding contact-tracing efforts across urban and rural areas in the eastern territory. Local health centers are receiving personal protective equipment, diagnostic reagents, and therapeutic supplies to enhance preparedness. The government confirmed that comprehensive public health measures will stay in place until viral transmission metrics show consistent decline across all affected provinces.
The government urged communities to cooperate fully with mobile vaccination teams and follow established sanitary protocols. It is expected that increasing immunization coverage among high-risk groups will help stabilize infection rates over the coming weeks. Surveillance networks will continue heightened monitoring at transportation hubs and border crossings to prevent further geographic spread.
